Cerity Partners’s Mesa Laboratories MLAB Stock Holding History

Cerity Partners’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$738K	Buy	7,413 +168	+2%	+$16.9K	﹤0.01%	2185
2026 Q1	$641K	Buy	7,245 +3,884	+116%	+$335K	﹤0.01%	2130
2025 Q4	$264K	Buy	+3,361	New	+$256K	﹤0.01%	2483
2023 Q2	–	Sell	-95	Closed	-$1.01M	–	1840
2023 Q1	$1.01M	Buy	+95	New	+$17K	﹤0.01%	968
2018 Q2	–	Sell	-5,725	Closed	-$850K	–	568
2018 Q1	$850K	Hold	5,725	–	–	0.07%	254
2017 Q4	$712K	Hold	5,725	–	–	0.05%	278
2017 Q3	$855K	Hold	5,725	–	–	0.06%	251
2017 Q2	$820K	Hold	5,725	–	–	0.07%	188
2017 Q1	$702K	Buy	+5,725	New	+$701K	0.06%	222

Other funds holding MLAB

LPP

Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Cerity Partners's MLAB Position: Q2 2026 in Review

Cerity Partners increased its Mesa Laboratories (MLAB) stake by 2.3% in Q2 2026, buying an estimated $16.9K and bringing the position to 7,413 shares worth $738K. The position accounts for ﹤0.01% of the portfolio, ranked #2185.

Cerity Partners first reported a position in MLAB in Q1 2017 and has held it in 9 quarters since. The position peaked at $1.01M in Q1 2023. 160 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

Cerity Partners held 7,413 shares of Mesa Laboratories worth $738K as of Q2 2026.
Cerity Partners bought 168 Mesa Laboratories shares in Q2 2026, an estimated $16.9K.
Mesa Laboratories made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2185 holding.
Cerity Partners first reported a position in Mesa Laboratories in Q1 2017 and has held it in 9 quarters since.
Cerity Partners's Mesa Laboratories position peaked at $1.01M in Q1 2023.
160 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.